A few weeks into making this a real weekly habit, and I'll tell you, the hard part isn't finding things to write about. It's stopping at ten. So much crosses my desk in a week, between running the homes, tinkering with my little software tools, and just being a person who reads too much, that the actual work is deciding what mattered versus what only felt loud.
So the deal is the same as always. I go through the week across the stuff I pay attention to, AI, medicine, money, a little wonder, and I write down what actually happened. Not predictions. Not somebody's hot take about where it's all going. Just the things that happened, with my own two cents attached, and I try hard to keep the two cents from swallowing the news.
This is mostly for me, honestly. An hour to slow down and pay attention to a world that doesn't slow down for anybody. But if any of it is useful to you, I'm glad you're here. Ten things, one sitting.
AI Makes Its Move
1. Apple finally showed its hand, and it's a rebuilt Siri
At its developer conference on June 8, Apple unveiled Siri AI, a from-scratch version of its assistant. And here is the part I did not expect.. it runs on Google's Gemini. Apple says it worked with Google on the next generation of its own foundation models, so the assistant on your iPhone is going to be part Apple and part Google. The new Siri can read what's on your screen, understand images, and pull up things it told you before, and it comes as its own app across iPhone, iPad, and Mac. Apple broke its usual format and announced six new operating systems at once, all jumping to version 27, plus a slider that lets you dial the glassy Liquid Glass look from clear to tinted. iOS 27 itself goes back to the iPhone 11, but the new Siri needs far newer hardware than that, and it won't ship in the European Union at launch on iPhone, iPad, or Watch.
Apple has been the obvious laggard in AI. They sat back while everybody else shipped, and they got roasted for a Siri upgrade they promised last year and then quietly delayed. So the interesting thing here isn't the feature list, it's the reach. When a genuinely capable assistant lands on more than a billion phones that people already own and trust, that's the moment AI stops being a thing you go to a website for and becomes a thing that's just there. If it actually works this time. Apple's earned a little skepticism on that last part.
2. The White House asked AI companies to hand over early access to their most powerful models
On June 2, President Trump signed an executive order aimed mostly at cybersecurity. It tells officials to build, within 60 days, a classified process, run by the director of the NSA, to test how good frontier AI models are at hacking, and to define what even counts as a frontier model. It also sets up a voluntary lane for companies to give the government a look at new models up to 30 days before they go public. Key word is voluntary. It's not licensing, and it leaves the big term, frontier model, undefined for now.
This is the most serious move Washington has made yet toward keeping an eye on the most powerful AI systems, and I think that's the right instinct even if the details are mushy. My honest read is that a voluntary program with undefined terms is a first draft, not a finished policy. But you can see the shape of where this goes. The government is starting to treat the top-tier models less like software and more like something closer to a strategic material. Whether that helps or just adds paperwork is going to come down to those definitions nobody's written yet.
Medicine Had a Big Week
3. The FDA approved the first pill you can take to prevent COVID after you've been exposed
On June 1, the FDA approved Shionogi's Xocova, generic name ensitrelvir, for people 12 and up who've been around someone infected with COVID. It's a five-day pill, and it's the first oral option aimed at stopping the infection before it takes hold rather than treating it after. The approval came ahead of schedule, on the strength of a trial that showed a 67 percent lower risk of coming down with symptomatic COVID in exposed people compared to a placebo.
I'll be honest, I didn't expect a headline like this in 2026. COVID mostly faded into the background of everyone's life, mine included. But the idea of a take-a-pill-after-exposure option is genuinely new, and it's the kind of quiet tool that matters most to households with someone fragile in them, or to anyone who can't afford to get knocked down for a week. Whether people actually use it is another question, and that usually comes down to price and whether anyone still bothers. But the science of it is a real step.
4. An experimental drug roughly doubled survival in pancreatic cancer, and the room gave it a standing ovation
At the big cancer research meeting in Chicago on May 31, results came out for a drug called daraxonrasib in previously treated metastatic pancreatic cancer, one of the deadliest diagnoses there is. In the trial, it cut the risk of death by about 60 percent versus chemotherapy. Median survival went from 6.7 months to 13.2 months, and the results were published in the New England Journal of Medicine the same day. The drug goes after a protein called RAS that scientists spent decades calling undruggable. Doctors in the room stood up and applauded, which if you know how these conferences usually go, tells you something.
Here's my caution, and it's a real one. This is a company-run trial, the drug isn't approved yet, and doubling survival in pancreatic cancer means going from terrible to slightly less terrible, not to a cure. But I don't want the caution to bury the news, because the news is big. Cracking RAS is something a lot of very smart people thought might never happen in our lifetimes. If it holds up through the approval process, this is the kind of thing that rewrites a chapter in the textbook.
Money and Main Street
5. The May jobs report beat expectations, but look closely and the gains are narrow
On June 5, the government reported that employers added 172,000 jobs in May, roughly double what economists expected, with unemployment holding at 4.3 percent. Sounds great on the surface. But three-quarters of the hiring came from just two places, restaurants and hospitality, and local government. Financial companies actually cut jobs. And the share of unemployed people who've been out of work long-term climbed to 27.5 percent, a high for this cycle.
This is what people mean when they call it a low-firing, low-hiring economy. If you already have a job, things feel stable. If you're trying to find one, it's a slog, and the longer you're out, the harder it gets. I pay attention to these reports the way any small operator does, because the headline number and the story underneath it are often two different things. A big beat that's really just restaurants and city hall isn't the broad, healthy hiring it looks like at a glance.
6. Small business owners are getting gloomier, and they're telling you why
On June 9, the main small-business sentiment survey, from the NFIB, showed optimism slipping again to 95.3, below its 52-year average. The uncertainty reading jumped. Inflation was named the single biggest problem by the most owners since late 2024, a net 36 percent raised or planned to raise their prices, and the share planning to invest in their businesses fell to the lowest level since 2009. The group's economist pointed straight at fuel costs.
I sit inside this number, so it doesn't read like an abstraction to me. Every cost that runs through a business like mine, food, wages, insurance, fuel, has gone up and mostly stayed up, and you feel it in the decisions you don't make. The plan you shelve. The hire you wait on. What this survey really captures is a mood, thousands of owners quietly deciding this isn't the year to reach. That mood tends to show up in the hard economic data a few months later, so it's worth watching.
7. Gas is still near four dollars, but it's finally coming down
On June 4, the national average for regular sat at $4.24 a gallon, down 18 cents in a week, the second straight weekly drop. The backdrop to all of this is the war with Iran and the temporary closing of the Strait of Hormuz, where something like a fifth of the world's oil moves. That shock pushed gas to a 2026 peak of $4.56 and made this past May the third most expensive month for gas in American history. Prices started easing as a preliminary deal to reopen the strait came together.
Gas is the one price everybody sees, several times a week, lit up on a sign taller than your car. So when it starts falling, it does more for how people feel about the economy than almost any government report. I became an EV owner recently, so I feel this one a little sideways now, watching the number instead of paying it. But the direction is the real story here. A falling pump price is the clearest sign the war shock is starting to fade.
Wonder and the Bigger Picture
8. NASA named the four people who'll rehearse the Moon landing, in Earth orbit
On June 9, NASA announced the crew for Artemis III: commander Randy Bresnik, pilot Luca Parmitano of the European Space Agency, and mission specialists Frank Rubio, who holds the American record for a single spaceflight at 371 days, and rookie Andre Douglas. The roughly two-week mission, targeted for as soon as late 2027, doesn't go to the Moon at all. It stays in Earth orbit. It's the rehearsal, testing how the crew rendezvous and docks with the lander systems being built by SpaceX and Blue Origin, before an actual landing they're aiming for in 2028.
I grew up on the idea of astronauts as almost mythical, and there's something that lands for me about it becoming concrete again. Real names. A real, if shaky, timeline. Private companies building the lander instead of just the government. It's easy to be cynical about how many times these dates have slipped, and they have. But four people now know they're the ones going, and that pulls the whole thing out of someday and into the work of getting ready.
9. A frozen little world way out past Neptune deepened the Planet Nine mystery
A distant object called 2023 KQ14, found by Japan's Subaru Telescope in Hawaii, came back around in the science pages this week. It swings out to about 433 times the Earth-Sun distance and never comes closer than about seventy, off at the cold edge of the solar system. For years, some scientists have argued that the strange, clustered orbits of a handful of far-out objects hint at a hidden ninth planet herding them. But this one's orbit is steadier and less herded than that theory predicts, which suggests that if there is a Planet Nine, it would have to be much farther out than anyone proposed, and it weakens the case for a nearer one.
No business angle here, and I'm not going to invent one. I just love that this is still an open question. We have telescopes that can read the atmosphere of planets around other stars, and yet we genuinely don't know whether our own solar system has an eighth planet or a ninth. There's something humbling in that. We keep looking, and the thing we're looking for keeps sliding a little further into the dark.
10. Alexander Zverev finally won his first major, after years of coming up short
On June 7, Germany's Alexander Zverev won the French Open, beating Italy's Flavio Cobolli in five sets. It was his first Grand Slam title on his fourth trip to a major final, after losing the other three, and it made him the first German man to win a major since Boris Becker back in 1996. He's also the first player in years who isn't named Sinner or Alcaraz to break through and win one.
I'll close on this one because I'm a sucker for the persistence stories, and this is a clean one. Zverev has been very good for a long time and kept losing the last match, the one that counts, which is a specific kind of hard that I think a lot of us understand. You can be excellent for years and still be missing the thing you're actually chasing. And then one day the last door opens. It doesn't always. But it's worth remembering, on the weeks the door stays shut, that the people who finally walk through it are usually the ones who kept showing up to knock.
A Note to Myself
That's the week. Ten things, one sitting.
If there's a thread this week, it's that most of the big stuff came with an asterisk. A rebuilt Siri that still has to prove it works. A cancer result that's real but early. A jobs beat that's narrower than it looks. I don't find that discouraging. The asterisk is just what honesty looks like in real time, before the story gets simplified into whatever we'll tell ourselves it was.
Mostly for me, like always. But if you read this far, thank you. See you next week.
